Prevalence of NRTI DRMs in ARV-Naive Patients
Last updated on 2015-2-9
K65R, D67d, T69i, K70R, L74I/V, Y115F, Q151M, M184I/V, T215F/Y
Table 5a. Prevalence of major NRTI DRMs in ARV-naive patients by region
Sub-Saharan Africa n=11628 87 with major DRMs | South/Southeast Asia n=6830 67 with major DRMs | Latin America n=5715 131 with major DRMs | Upper-income countries n=24898 782 with major DRMs |
| DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum |
| M184V | 64.3 | 64.3 | M184V | 54.1 | 54.1 | M184V | 68.8 | 68.8 | M184V | 52.1 | 52.1 |
| K70R | 20.2 | 72.6 | L74I | 13.1 | 65.6 | K70R | 24.0 | 81.2 | T215Y | 31.4 | 72.1 |
| Y115F | 7.1 | 79.8 | M184I | 13.1 | 77.0 | T215Y | 24.0 | 91.7 | K70R | 24.4 | 87.5 |
| K65R | 7.1 | 86.9 | K70R | 13.1 | 86.9 | M184I | 5.2 | 94.8 | K65R | 5.3 | 91.2 |
| M184I | 6.0 | 92.9 | K65R | 13.1 | 95.1 | T215F | 12.5 | 97.9 | T215F | 10.8 | 94.1 |
| L74I | 4.8 | 95.2 | Y115F | 1.6 | 96.7 | L74I | 2.1 | 99.0 | L74V | 6.8 | 95.8 |
| T215Y | 19.0 | 97.6 | L74V | 4.9 | 98.4 | K65R | 2.1 | 100.0 | M184I | 3.5 | 97.4 |
| L74V | 6.0 | 98.8 | T215F | 6.6 | 100.0 | L74V | 3.1 | - | Q151M | 3.3 | 98.7 |
| T215F | 11.9 | 100.0 | T215Y | 13.1 | - | Q151M | 1.0 | - | L74I | 4.8 | 99.8 |
| Q151M | 0.0 | - | Q151M | 4.9 | - | D67d | 0.0 | - | Y115F | 2.9 | 100.0 |
| D67d | 0.0 | - | D67d | 0.0 | - | T69i | 0.0 | - | D67d | 0.0 | - |
| T69i | 0.0 | - | T69i | 0.0 | - | Y115F | 0.0 | - | T69i | 0.0 | - |
Footnotes:
- The prevalence of all DRMs including those with lower scores can be queried using the form at the following page: Prevalence of DRMs in ARV-Naive Patients
Table 5b. Prevalence of major NRTI DRMs in ARV-naive patients by subtype
A n=3408 27 with major DRMs | B n=26882 275 with major DRMs | C n=7519 29 with major DRMs | D n=1295 19 with major DRMs | G n=1450 9 with major DRMs | 01 n=5499 33 with major DRMs | 02 n=2706 7 with major DRMs |
| DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum |
| M184V | 67.5 | 67.5 | M184V | 53.7 | 53.7 | M184V | 60.4 | 60.4 | M184V | 79.2 | 79.2 | M184V | 60.0 | 60.0 | M184V | 61.1 | 61.1 | M184V | 50.0 | 50.0 |
| T215F | 15.0 | 100 | T215Y | 29.7 | 100 | T215Y | 18.8 | 100 | T215Y | 41.7 | 100 | T215Y | 20.0 | 100 | K65R | 13.0 | 100 | K70R | 28.6 | 100 |
| T215Y | 15.0 | 100 | K70R | 26.0 | 100 | T215F | 14.6 | 100 | K70R | 29.2 | 100 | K65R | 13.3 | 100 | K70R | 13.0 | 100 | Y115F | 28.6 | 100 |
| K70R | 12.5 | 100 | T215F | 10.5 | 100 | K70R | 10.4 | 100 | Y115F | 4.2 | 100 | L74I | 6.7 | 100 | L74I | 11.1 | 100 | T215Y | 14.3 | 100 |
| K65R | 7.5 | 100 | L74V | 6.4 | 100 | M184I | 10.4 | 100 | T215F | 8.3 | - | M184I | 6.7 | 100 | T215Y | 11.1 | 100 | M184I | 7.1 | 100 |
| L74I | 7.5 | 100 | M184I | 4.5 | 100 | K65R | 8.3 | 100 | L74I | 4.2 | - | Y115F | 6.7 | 100 | M184I | 5.6 | 100 | L74I | 14.3 | - |
| M184I | 7.5 | 100 | K65R | 4.3 | 100 | L74V | 6.2 | 100 | D67d | 0 | | K70R | 13.3 | - | T215F | 5.6 | 100 | L74V | 7.1 | - |
| L74V | 2.5 | 100 | L74I | 4.3 | 100 | L74I | 4.2 | 100 | K65R | 0 | | T215F | 13.3 | - | L74V | 3.7 | 100 | T215F | 7.1 | - |
| Y115F | 2.5 | 100 | Q151M | 3.3 | 100 | Y115F | 2.1 | 100 | L74V | 0 | | L74V | 6.7 | - | Q151M | 3.7 | - | D67d | 0 | |
| D67d | 0 | | Y115F | 2.3 | 100 | D67d | 0 | | M184I | 0 | | Q151M | 6.7 | - | D67d | 0 | | K65R | 0 | |
| Q151M | 0 | | D67d | 0 | | Q151M | 0 | | Q151M | 0 | | D67d | 0 | | T69i | 0 | | Q151M | 0 | |
| T69i | 0 | | T69i | 0 | | T69i | 0 | | T69i | 0 | | T69i | 0 | | Y115F | 0 | | T69i | 0 | |
Footnotes:
- The prevalence of all DRMs including those with lower scores can be queried using the form at the following page: Prevalence of DRMs in ARV-Naive Patients